Drug Shortage Report for GALANTAMINE ER
| Report ID | 119747 |
| Drug Identification Number | 02443015 |
| Brand name | GALANTAMINE ER |
| Common or Proper name | GALANTAMINE |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-08 |
| Estimated end date | 2021-01-04 |
| Actual end date | 2021-02-09 |
| Shortage status | Resolved |
| Updated date | 2021-02-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2021-02-10 | English | Compare |
| v9 | 2021-02-09 | French | Compare |
| v8 | 2021-02-09 | English | Compare |
| v7 | 2020-12-10 | French | Compare |
| v6 | 2020-12-10 | English | Compare |
| v5 | 2020-10-20 | French | Compare |
| v4 | 2020-10-20 | English | Compare |
| v3 | 2020-07-09 | English | Compare |
| v2 | 2020-07-08 | French | Compare |
| v1 | 2020-07-08 | English | Compare |
Showing 1 to 10 of 10